Carrie Strom - 07 Feb 2022 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
SVP & Pres Global Allerg Aesth
Signature
Steven L. Scrogham, attorney-in-fact for Carrie Strom
Issuer symbol
ABBV
Transactions as of
07 Feb 2022
Transactions value $
$-140,466
Form type
4
Filing time
08 Feb 2022, 16:13:24 UTC
Previous filing
05 Jan 2022
Next filing
22 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABBV Common Stock, $0.01 par value Award $197,778 +4,184 +10.3% $47.27 44,895 07 Feb 2022 Direct
transaction ABBV Common Stock, $0.01 par value Sale $-338,243 -2,396 -5.34% $141.17 42,499 07 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABBV Option (right to buy) Options Exercise $0 +4,184 $0.000000* 0 07 Feb 2022 Common Stock 4,184 $47.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

The transaction reported on this Form 4 was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).